Summary of opinion: Startvac, 16/04/2026 Positive

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPChFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia, feline chlamydiosis (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 April 2026

EMA recommends authorisation of first veterinary vaccine using RNA technology

Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation: 24/03/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation: 22/08/2007, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 9, Status: Authorised

Recommendations on medication errors